Skip to content
Toggle Navigation
Home
About
Services
Regulatory Affairs Services
Pharmacovigilance Services
Clinical Trials & Research Services
Quality Services
Insights
Resources
Patients
Report Side Effects
Search for:
English
عربي
Contact Us
Author: المحرر التنظيمي
Published by regulatory affairs team in PharmaKnowl, Riyadh office.
Biosimilars Registration: SFDA Considerations
CAR T Cell Registration in SFDA
Understanding RMP & RMMs in SFDA PV Regulation
Scientific Office License Requirements by SFDA
Saudi Pharmacovigilance Sub System File (PSSF)
SFDA Timelines
SFDA Reference Countries
Signal Management Workshop (March 2023 Riyadh)
Periodic Safety Update Report (PSUR) Submission to SFDA
SFDA Sunsets the MDNR Procedure for Low-Risk Medical Devices
SFDA Labelling Requirements (SPC, PIL, IFU, Artworks)
NDLP: Saudi Pharmaceutical Market is expected at $11.7 billion by 2030 (Medical Devices Included)
Previous
1
2
3
Next
Page load link
Go to Top
